153 related articles for article (PubMed ID: 30841579)
1. Cytoplasmic Interactions between the Glucocorticoid Receptor and HDAC2 Regulate Osteocalcin Expression in VPA-Treated MSCs.
La Noce M; Mele L; Laino L; Iolascon G; Pieretti G; Papaccio G; Desiderio V; Tirino V; Paino F
Cells; 2019 Mar; 8(3):. PubMed ID: 30841579
[TBL] [Abstract][Full Text] [Related]
2. Histone deacetylase inhibition with valproic acid downregulates osteocalcin gene expression in human dental pulp stem cells and osteoblasts: evidence for HDAC2 involvement.
Paino F; La Noce M; Tirino V; Naddeo P; Desiderio V; Pirozzi G; De Rosa A; Laino L; Altucci L; Papaccio G
Stem Cells; 2014 Jan; 32(1):279-89. PubMed ID: 24105979
[TBL] [Abstract][Full Text] [Related]
3. Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
Cho HH; Park HT; Kim YJ; Bae YC; Suh KT; Jung JS
J Cell Biochem; 2005 Oct; 96(3):533-42. PubMed ID: 16088945
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid promotes neuronal differentiation by induction of neuroprogenitors in human bone-marrow mesenchymal stromal cells.
Jeong SG; Ohn T; Kim SH; Cho GW
Neurosci Lett; 2013 Oct; 554():22-7. PubMed ID: 24021810
[TBL] [Abstract][Full Text] [Related]
5. HDAC inhibitors dysregulate neural stem cell activity in the postnatal mouse brain.
Foti SB; Chou A; Moll AD; Roskams AJ
Int J Dev Neurosci; 2013 Oct; 31(6):434-47. PubMed ID: 23542004
[TBL] [Abstract][Full Text] [Related]
6. Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells.
Yu Y; Oh SY; Kim HY; Choi JY; Jo SA; Jo I
Cells; 2022 Feb; 11(3):. PubMed ID: 35159343
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid receptor and histone deacetylase-2 mediate dexamethasone-induced repression of MUC5AC gene expression.
Chen Y; Watson AM; Williamson CD; Rahimi M; Liang C; Colberg-Poley AM; Rose MC
Am J Respir Cell Mol Biol; 2012 Nov; 47(5):637-44. PubMed ID: 22798432
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid receptor and Histone deacetylase 6 mediate the differential effect of dexamethasone during osteogenesis of mesenchymal stromal cells (MSCs).
Rimando MG; Wu HH; Liu YA; Lee CW; Kuo SW; Lo YP; Tseng KF; Liu YS; Lee OK
Sci Rep; 2016 Nov; 6():37371. PubMed ID: 27901049
[TBL] [Abstract][Full Text] [Related]
9. The Selective Histone Deacetylase Inhibitor MI192 Enhances the Osteogenic Differentiation Efficacy of Human Dental Pulp Stromal Cells.
Man K; Lawlor L; Jiang LH; Yang XB
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069280
[TBL] [Abstract][Full Text] [Related]
10. HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy.
La Noce M; Paino F; Mele L; Papaccio G; Regad T; Lombardi A; Papaccio F; Desiderio V; Tirino V
J Exp Clin Cancer Res; 2018 Dec; 37(1):296. PubMed ID: 30509303
[TBL] [Abstract][Full Text] [Related]
11. Effect of valproic acid on the hepatic differentiation of mesenchymal stem cells in 2D and 3D microenvironments.
Rashid S; Qazi RE; Malick TS; Salim A; Khan I; Ilyas A; Haneef K
Mol Cell Biochem; 2021 Feb; 476(2):909-919. PubMed ID: 33111212
[TBL] [Abstract][Full Text] [Related]
12. Targeting AML1/ETO-histone deacetylase repressor complex: a novel mechanism for valproic acid-mediated gene expression and cellular differentiation in AML1/ETO-positive acute myeloid leukemia cells.
Liu S; Klisovic RB; Vukosavljevic T; Yu J; Paschka P; Huynh L; Pang J; Neviani P; Liu Z; Blum W; Chan KK; Perrotti D; Marcucci G
J Pharmacol Exp Ther; 2007 Jun; 321(3):953-60. PubMed ID: 17389244
[TBL] [Abstract][Full Text] [Related]
13. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity.
Fu Y; Zhang P; Ge J; Cheng J; Dong W; Yuan H; Du Y; Yang M; Sun R; Jiang H
Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367
[TBL] [Abstract][Full Text] [Related]
14. Valproic acid, but not levetiracetam, selectively decreases HDAC7 and HDAC2 expression in human ovarian cancer cells.
Kwiecińska P; Wróbel A; Taubøll E; Gregoraszczuk EŁ
Toxicol Lett; 2014 Jan; 224(2):225-32. PubMed ID: 24200999
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells.
Lee S; Park JR; Seo MS; Roh KH; Park SB; Hwang JW; Sun B; Seo K; Lee YS; Kang SK; Jung JW; Kang KS
Cell Prolif; 2009 Dec; 42(6):711-20. PubMed ID: 19689470
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells.
Matsumoto Y; Otsuka F; Takano M; Mukai T; Yamanaka R; Takeda M; Miyoshi T; Inagaki K; Sada KE; Makino H
Mol Cell Endocrinol; 2010 Aug; 325(1-2):118-27. PubMed ID: 20638987
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of TrkB Expression and Signaling by Valproic Acid and Other Histone Deacetylase Inhibitors.
Dedoni S; Marras L; Olianas MC; Ingianni A; Onali P
J Pharmacol Exp Ther; 2019 Sep; 370(3):490-503. PubMed ID: 31308194
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of histone deacetylase 2 expression by elevated glucocorticoid receptor beta in steroid-resistant asthma.
Li LB; Leung DY; Martin RJ; Goleva E
Am J Respir Crit Care Med; 2010 Oct; 182(7):877-83. PubMed ID: 20538962
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of histone deacetylases potentiates BMP9-induced osteogenic signaling in mouse mesenchymal stem cells.
Hu N; Wang C; Liang X; Yin L; Luo X; Liu B; Zhang H; Shui W; Nan G; Wang N; Wu N; Chen X; He Y; Wen S; Deng F; Zhang H; Liao Z; Luu HH; Haydon RC; He TC; Huang W
Cell Physiol Biochem; 2013; 32(2):486-98. PubMed ID: 23988723
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid enhances the neural differentiation of human placenta derived-mesenchymal stem cells in vitro.
Talwadekar M; Fernandes S; Kale V; Limaye L
J Tissue Eng Regen Med; 2017 Nov; 11(11):3111-3123. PubMed ID: 27781405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
